Abstract
Suicide is among the leading causes of death in youth worldwide. Early identification of children with high risk for suicide is key to effective screening and prevention strategies. Brain imaging can show functional or structural abnormalities related to youth suicidality, but literature is scarce. Here we tested the extent to which brain imaging is useful in predicting suicidal risk in children. In the largest to date, multi-site, multi-ethnic, epidemiological developmental samples in the US (N = 6,172; the ABCD study), we trained and validated machine learning models and deep neural networks on the multimodal brain imaging derived phenotypes (morphometry, white matter connectivity, functional activation, and connectivity) along with behavioral and self-reported psychological questionnaire data. The model trained on diffusion white matter connectomes showed the best performance (test AUC-ROC = 74.82) with a one percentage increase compared with the baseline model trained on behavioral and psychological data (test AUC-ROC = 74.16). Models trained on other MRI modalities showed similar but slightly lower performances. Model interpretation showed the important brain features involved in attention, emotion regulation, and motor coordination, such as the anterior cingulate cortex, temporal gyrus, and precentral gyrus. It further showed that the interaction of brain features with depression and impulsivity measures contributed to the optimal prediction of youth suicidality. This study demonstrates the potential utility of a multimodal brain imaging approach to youth suicidality prediction and uncovers the relationships of the psychological and multi-dimensional and multi-modal neural features to youth suicidality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the New Faculty Startup Fund from Seoul National University (Cha); the BK21 FOUR Program (5199990314123) through the National Research Foundation of Korea (Cha and Ahn); National IT Promotion Agency GPU award (Cha); Intel PRTI award (Cha).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Most ABCD research sites attained a central Institutional Reveiw Board (IRB) at the University of California, San Diego, with a few sites relying on local IRB approval. The analysis was approved by the IRB of Seoul National University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The ABCD data can be accessed via the NIMH Data Archive (https://nda.nih.gov/). Our codes used in this study are freely accessible: for the Tabnet implementation (https://colab.research.google.com/drive/1y5I89AxrfGYAlJmW2jnYk42OOlDfP8Zz?usp=sharing) and for the ensemble modeling (https://colab.research.google.com/drive/1lR1Y5BBEuGtxQfDDYZ2RL9EtL__h_Jxf?usp=sharing)
